Open AccessActivity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile
Author(s) -
Tarun Mathur,
Manoj Kumar,
Tarani Kanta Barman,
Guneet Kumar,
Vandana Kalia,
Sanjay Singhal,
Vethakkani Samuel Raj,
Dilip J. Upadhyay,
Biswajit Das,
Pradip K. Bhatnagar
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr033
Subject(s) - clostridium difficile , microbiology and biotechnology , metronidazole , vancomycin , in vivo , clostridium difficile toxin a , clostridium , bacteroides fragilis , anaerobic bacteria , chemistry , biology , antibiotics , pharmacology , bacteria , staphylococcus aureus , genetics
RBx 11760, a novel oxazolidinone, was investigated for in vitro and in vivo activity against Clostridium difficile.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom